Underdosing of systemic and hematological agents is a common problem in clinical practice. It refers to the use of a lower dose of a drug than recommended or required to achieve the desired therapeutic effect. Underdosing can occur due to various reasons, including patient factors, prescriber factors, and system factors.
Underdosing of systemic and hematological agents can have several consequences. It can lead to inadequate therapeutic effects, treatment failure, disease progression, and increased morbidity and mortality. Underdosing can also lead to the development of drug resistance, which can make treatment more challenging in the future.
It is essential to identify the causes of underdosing and take steps to prevent it. Prescribers should be aware of the appropriate dose of the drug for each patient and take into account the patient's age, weight, kidney function, liver function, and other comorbidities. They should also be aware of the patient's medication history and current drug regimen to avoid drug interactions and underdosing. Patients should be educated about the importance of taking their medications as prescribed and reporting any adverse effects to their healthcare providers.
In conclusion, underdosing of systemic and hematological agents is a common problem that can have significant consequences. Prescribers and healthcare providers should take steps to identify the causes of underdosing and take appropriate measures to prevent it. Patients should also be educated about the importance of taking their medications as prescribed and reporting any adverse effects to their healthcare providers.